The mode of action of immunosuppressive agents.
D000477:Alkylating Agents / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D000893:Anti-Inflammatory Agents; D000961:Antilymphocyte Serum / Q000494:pharmacology; D001379:Azathioprine / Q000378:metabolism / Q000494:pharmacology; D002470:Cell Survival / Q000187:drug effects; D003520:Cyclophosphamide / Q000494:pharmacology; D005938:Glucocorticoids / Q000378:metabolism / Q000494:pharmacology; D006801:Humans; D007154:Immune System Diseases / Q000188:drug therapy; D007109:Immunity / Q000187:drug effects; D007111:Immunity, Cellular / Q000187:drug effects; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D066298:In Vitro Techniques; D015122:Mercaptopurine / Q000378:metabolism / Q000494:pharmacology; D008660:Metabolism / Q000187:drug effects; D013866:Thioguanine / Q000494:pharmacology
D000477:Alkylating Agents; D000893:Anti-Inflammatory Agents; D000961:Antilymphocyte Serum; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D015122:Mercaptopurine; D013866:Thioguanine; D001379:Azathioprine